| Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors (NCT02950467) | Joshua Woolley | 2018-01-05 |
| A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women (NCT03270969) | University of Nebraska | 2018-01-05 |
| Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma (NCT03355859) | Zhao Weili | 2018-01-05 |
| Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer (NCT03380689) | Fujian Cancer Hospital | 2018-01-05 |
| Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03122106) | Washington University School of Medicine | 2018-01-05 |
| Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors (NCT03373097) | Bambino Gesù Hospital and Research Institute | 2018-01-05 |
| Clinical Study of CN128 in Thalassemia Patients (NCT03673085) | Hangzhou Zede Pharma-Tech Co., Ltd. | 2018-01-05 |
| A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529 (NCT03400995) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2018-01-05 |
| Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics (NCT03392779) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2018-01-05 |
| PSMA-PET/CT for Prostate Cancer (NCT03558711) | University Hospital, Ghent | 2018-01-04 |
| A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC) (NCT03316794) | AbbVie | 2018-01-04 |
| A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy (NCT03086291) | Samsung Medical Center | 2018-01-04 |
| A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) (NCT03375164) | Sarepta Therapeutics, Inc. | 2018-01-04 |
| Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types) (NCT03375632) | Mochida Pharmaceutical Company, Ltd. | 2018-01-04 |
| A Study to Evaluate the Bioavailability of BMS-986205 (NCT03374228) | Bristol-Myers Squibb | 2018-01-04 |
| A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 (Sebetralstat) in Healthy Volunteers (NCT04349800) | KalVista Pharmaceuticals, Ltd. | 2018-01-04 |
| Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies (NCT03367819) | Sanofi | 2018-01-04 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis (NCT03337022) | Celgene | 2018-01-04 |
| Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors (NCT03237390) | Mayo Clinic | 2018-01-04 |
| Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS (NCT03074006) | MedPacto, Inc. | 2018-01-04 |
| S 81694 Plus Paclitaxel in Metastatic Breast Cancer (NCT03411161) | Institut de Recherches Internationales Servier | 2018-01-04 |
| A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies (NCT03088878) | Oncternal Therapeutics, Inc | 2018-01-03 |
| ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists (NCT03445715) | Arthrogen | 2018-01-03 |
| Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma (NCT02729961) | University of Washington | 2018-01-03 |
| Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID (NCT03765632) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2018-01-03 |
| Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus (NCT03414892) | Yabao Pharmaceutical Group | 2018-01-03 |
| Bioequivalence Study of Lu AF35700 (NCT03394482) | H. Lundbeck A/S | 2018-01-03 |
| Salvage Peanut Oral Immunotherapy Study (NCT03251508) | University of North Carolina, Chapel Hill | 2018-01-03 |
| D-0316 First Time in Patients Ascending Dose Study (NCT03452150) | InventisBio Co., Ltd | 2018-01-03 |
| A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide (NCT03387657) | Sanofi | 2018-01-03 |
| A Study of LY3209590 in Participants With Type 2 Diabetes (NCT03367377) | Eli Lilly and Company | 2018-01-03 |
| A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF) (NCT02871401) | Vanderbilt University Medical Center | 2018-01-03 |
| Comparison of Naloxone Pharmacokinetics (NCT03386591) | National Institute on Drug Abuse (NIDA) | 2018-01-03 |
| A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants (NCT03405441) | Janssen Research & Development, LLC | 2018-01-02 |
| A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma (NCT03398967) | Chinese PLA General Hospital | 2018-01-02 |
| Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN (NCT03386513) | AbbVie | 2018-01-02 |
| Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours (NCT03415100) | The Third Affiliated Hospital of Guangzhou Medical University | 2018-01-02 |
| A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms (NCT03511768) | Xiangya Hospital of Central South University | 2018-01-02 |
| Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors (NCT03352531) | Akesobio Australia Pty Ltd | 2018-01-02 |
| Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin (NCT03259581) | University of Minnesota | 2018-01-02 |
| Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors (NCT03864042) | Pfizer | 2018-01-02 |
| An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung (NCT03371381) | Janssen Research & Development, LLC | 2018-01-02 |
| A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers (NCT06188325) | Sanofi | 2018-01-01 |
| CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma (NCT03427476) | Cancer Targeted Technology | 2018-01-01 |
| Endovascular Stenting Treatment for Patients With Internal Jugular Vein Stenosis (NCT03373292) | Capital Medical University | 2018-01-01 |
| Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis (NCT03506919) | Shifa Ul Mulk Memorial Hospital | 2018-01-01 |
| Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor (NCT03523754) | Dina Yahia Mansour | 2018-01-01 |
| A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps (NCT02623478) | Eli Lilly and Company | 2018-01-01 |
| Phase I Study of the Combination of Apatinib and POF (NCT03244774) | Fujian Cancer Hospital | 2018-01-01 |
| CKDu Treated With Intra-arterial Infusion of Autologous SVF Cells (NCT05154591) | Samuel Vilchez, PhD | 2018-01-01 |
| Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN) (NCT03258359) | PersImmune, Inc | 2018-01-01 |
| Silver Nanoparticle Investigation for Treating Chronic Sinusitis (NCT03243201) | Washington University School of Medicine | 2018-01-01 |
| A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy (NCT02623465) | Eli Lilly and Company | 2018-01-01 |
| Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma (NCT03468153) | Ruijin Hospital | 2018-01-01 |
| Cardiac MRI for Optimal Heart Failure Outcomes With CRT Upgrades (NCT03504891) | University of Virginia | 2018-01-01 |
| DCHA as Postremission Therapy for AML With t(8;21) (NCT03453255) | Chinese PLA General Hospital | 2018-01-01 |
| A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy (NCT02623452) | Eli Lilly and Company | 2018-01-01 |
| ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors (NCT06556108) | Xinqiao Hospital of Chongqing | 2018-01-01 |
| A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML (NCT02973711) | University of Michigan Rogel Cancer Center | 2018-01-01 |
| Sildenafil Citrate in Early Unexplained Recurrent Pregnancy Loss (NCT03766594) | Ain Shams University | 2018-01-01 |
| Effect of Low-intensity Laser and Photodynamic Therapy on Infected Dentin of Permanent Teeth With MIH (NCT03826810) | University of Nove de Julho | 2018-01-01 |
| Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome (NCT03840538) | Cairo University | 2018-01-01 |
| Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC (NCT02686008) | Yale University | 2018-01-01 |
| A Bioavailability Study on Dronabinol (NCT03098940) | Axim Biotechnologies | 2018-01-01 |
| Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake (NCT03449927) | Washington University School of Medicine | 2018-01-01 |
| Niosomal Propolis as Oromucoadhesive Film: In-vitro, Ex-vivo & In-vivo Investigations (NCT03615820) | British University In Egypt | 2018-01-01 |
| Laser Tissue Welding - Distal Pancreatectomy Sealing Study (NCT03147768) | Laser Tissue Welding, Inc. | 2018-01-01 |
| Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody (NCT03282435) | Dalian University | 2018-01-01 |
| Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor (NCT03551795) | Xiaoyan Zhang | 2018-01-01 |
| Dexamethasone and Induction of Delivery (NCT03658590) | samar sayed el sayed | 2018-01-01 |
| Treatment and Clinical Outcomes Among SLE Patients in Pregnancy (NCT04976465) | Qilu Hospital of Shandong University | 2018-01-01 |
| Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases (NCT02755428) | Chinese Academy of Sciences | 2018-01-01 |
| Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer (NCT03051906) | Azienda Ospedaliero-Universitaria Careggi | 2018-01-01 |
| Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial (NCT02672995) | National Taiwan University Hospital | 2018-01-01 |
| Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model (NCT03195387) | Medicines for Malaria Venture | 2018-01-01 |
| Treatment of Gingival Recession Using Mesenchymal Stem Cells (NCT04434794) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2018-01-01 |
| Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma (NCT03100877) | City of Hope Medical Center | 2018-01-01 |
| The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments (NCT05145686) | Ege University | 2018-01-01 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection (NCT03239223) | Antiva Biosciences | 2018-01-01 |
| The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients (NCT03224572) | National Taiwan University Hospital | 2018-01-01 |
| Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn (NCT03237442) | Guangzhou Saliai Stem Cell Science and Technology Co. Ltd. | 2018-01-01 |
| Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors (NCT03398720) | Jiangsu HengRui Medicine Co., Ltd. | 2017-12-31 |
| Optimal Balance Alfapump® System Feasibility Study (NCT03032211) | Sequana Medical N.V. | 2017-12-31 |
| Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies (NCT03098355) | Zhujiang Hospital | 2017-12-30 |
| A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants (NCT03758339) | Cascadian Therapeutics Inc. | 2017-12-30 |
| A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03369808) | Shanghai Institute Of Biological Products | 2017-12-29 |
| Her2-BATS and Pembrolizumab in Metastatic Breast Cancer (NCT03272334) | University of Virginia | 2017-12-29 |
| To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen (NCT03567941) | Sun Pharma Advanced Research Company Limited | 2017-12-29 |
| CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) (NCT03328078) | Curis, Inc. | 2017-12-28 |
| Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel (NCT03392051) | Akcea Therapeutics | 2017-12-28 |
| Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers (NCT03366974) | Seoul National University Hospital | 2017-12-28 |
| Misoprostol Versus Active Management of Labour in CS (NCT03390010) | Aljazeera Hospital | 2017-12-28 |
| QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy (NCT03387098) | ImmunityBio, Inc. | 2017-12-28 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366 (NCT03378648) | Chiesi Farmaceutici S.p.A. | 2017-12-28 |
| A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) (NCT03337698) | Hoffmann-La Roche | 2017-12-27 |
| MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer (NCT03300817) | National Cancer Institute (NCI) | 2017-12-27 |
| Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States (NCT03382418) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-12-27 |
| QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803 (NCT03381586) | Altor BioScience | 2017-12-27 |
| Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer (NCT03290937) | M.D. Anderson Cancer Center | 2017-12-27 |
| A Study to Evaluate the Food-Effect of H3B-6527 (NCT03424577) | Eisai Inc. | 2017-12-27 |